Clopidogrel Bisulfate Tablet 75 mg, 300 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 75 mg, 300 mg
Reference Brands: Plavix(US & EU)
Category: Blood Disorder
Clopidogrel inhibits the P2Y12 receptor on platelets, preventing ADP-induced activation and aggregation. It reduces the risk of blood clots, stroke, and heart attack, providing effective antiplatelet therapy. Benefits include oral administration, proven efficacy in cardiovascular prevention, and long-term safety for patients at risk of thrombotic events.
Product Description:
Clopidogrel is approved in both the US by the FDA and in the EU through EMA authorization for preventing blood clots in cardiovascular disease. Regulatory approval requires a detailed dossier demonstrating safety, efficacy, pharmacovigilance, and manufacturing quality. In the US, approval involves submission of comprehensive clinical data, while the EU mandates adherence to regional guidelines, including stability and bioequivalence studies. For guidance on dossier preparation, regulatory strategies, and successful market entry, visit PharmaTradz. Ensuring regulatory compliance is essential for the effective and safe commercialization of clopidogrel tablets worldwide, supporting cardiovascular patient care.
Clopidogrel Bisulfate Tablet — third party manufacturing & bulk supply
Clopidogrel Bisulfate Tablet 75 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Clopidogrel Bisulfate Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Clopidogrel Bisulfate Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Clopidogrel bisulfate is used to reduce the risk of heart attack and stroke in people with cardiovascular diseases such as recent myocardial infarction, recent stroke, or established peripheral arterial disease. It is also used in patients with acute coronary syndrome to prevent blood clots that can block blood vessels.
Clopidogrel bisulfate is a chemically synthesized antiplatelet agent. It is the bisulfate salt form of clopidogrel, which enhances the stability and bioavailability of the active substance in the body.
Clopidogrel bisulfate is marketed under several trade names globally, the most well-known being Plavix.
The original brand Plavix was developed and marketed by Sanofi and Bristol-Myers Squibb. Today, clopidogrel bisulfate is manufactured by multiple pharmaceutical companies worldwide as both branded and generic versions.
The generic name is clopidogrel bisulfate.
Common brand names include Plavix and various country-specific branded generics.
Clopidogrel bisulfate is manufactured in multiple countries, including the USA, EU nations, India, and other regions, by approved pharmaceutical manufacturers following regulatory standards.
Related Products
Anagrelide Hydrochloride
Strength:
0.5 mg
Form: Capsules
Reference Brands: Agrylin (USA)
View Details
Ferric Maltol
Strength:
30 mg
Form: Capsules
Reference Brands: Accrufer (USA), Feraccru (EU)
View Details
Lusutrombopag
Strength:
3 mg
Form: Tablets
Reference Brands: Mulpleta (USA), Mulpleo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
